Top 5 Stocks to Buy Now
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free RTW Stock Alerts

RTW Biotech Opportunities (RTW) Competitors

RTW Biotech Opportunities logo
GBX 2.24 +0.02 (+0.90%)
As of 06/23/2026 12:22 PM Eastern
Compare

RTW vs. CIP, RSE, PGIT, DNE, and DGI9

Should you buy RTW Biotech Opportunities stock or one of its competitors? MarketBeat compares RTW Biotech Opportunities with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with RTW Biotech Opportunities include CIP Merchant Capital (CIP), Riverstone Energy (RSE), Premier Global Infrastructure Trust PLC (PGIT.L) (PGIT), Dunedin Enterprise Investment Trust (DNE), and Digital 9 Infrastructure (DGI9). These companies are all part of the "asset management" industry.

How does RTW Biotech Opportunities compare to CIP Merchant Capital?

RTW Biotech Opportunities (LON:RTW) and CIP Merchant Capital (LON:CIP) are both small-cap asset management industry companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

3.1% of RTW Biotech Opportunities shares are held by institutional investors. 0.6% of RTW Biotech Opportunities shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

RTW Biotech Opportunities has higher revenue and earnings than CIP Merchant Capital. CIP Merchant Capital is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04
CIP Merchant Capital£8.87M0.00N/A£13.70N/A

In the previous week, RTW Biotech Opportunities' average media sentiment score of 0.00 equaled CIP Merchant Capital'saverage media sentiment score.

Company Overall Sentiment
RTW Biotech Opportunities Neutral
CIP Merchant Capital Neutral

RTW Biotech Opportunities has a net margin of 158.61% compared to CIP Merchant Capital's net margin of 0.00%. RTW Biotech Opportunities' return on equity of 36.01% beat CIP Merchant Capital's return on equity.

Company Net Margins Return on Equity Return on Assets
RTW Biotech Opportunities158.61% 36.01% -0.47%
CIP Merchant Capital N/A N/A N/A

Summary

RTW Biotech Opportunities beats CIP Merchant Capital on 6 of the 8 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to Riverstone Energy?

RTW Biotech Opportunities (LON:RTW) and Riverstone Energy (LON:RSE) are both small-cap financial services companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

RTW Biotech Opportunities has a beta of 1.238194, indicating that its stock price is 24% more volatile than the broader market. Comparatively, Riverstone Energy has a beta of 0.115, indicating that its stock price is 89% less volatile than the broader market.

In the previous week, RTW Biotech Opportunities' average media sentiment score of 0.00 equaled Riverstone Energy'saverage media sentiment score.

Company Overall Sentiment
RTW Biotech Opportunities Neutral
Riverstone Energy Neutral

RTW Biotech Opportunities has higher revenue and earnings than Riverstone Energy. Riverstone Energy is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04
Riverstone Energy£31.65M0.87£78.63M-£2.17N/A

3.1% of RTW Biotech Opportunities shares are held by institutional investors. Comparatively, 26.3% of Riverstone Energy shares are held by institutional investors. 0.6% of RTW Biotech Opportunities shares are held by insiders. Comparatively, 66.9% of Riverstone Energy shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

RTW Biotech Opportunities has a net margin of 158.61% compared to Riverstone Energy's net margin of -0.58%. RTW Biotech Opportunities' return on equity of 36.01% beat Riverstone Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
RTW Biotech Opportunities158.61% 36.01% -0.47%
Riverstone Energy -0.58%-0.20%-0.22%

Summary

RTW Biotech Opportunities beats Riverstone Energy on 7 of the 11 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to Premier Global Infrastructure Trust PLC (PGIT.L)?

RTW Biotech Opportunities (LON:RTW) and Premier Global Infrastructure Trust PLC (PGIT.L) (LON:PGIT) are both small-cap asset management industry companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

In the previous week, RTW Biotech Opportunities' average media sentiment score of 0.00 equaled Premier Global Infrastructure Trust PLC (PGIT.L)'saverage media sentiment score.

Company Overall Sentiment
RTW Biotech Opportunities Neutral
Premier Global Infrastructure Trust PLC (PGIT.L) Neutral

RTW Biotech Opportunities has a net margin of 158.61% compared to Premier Global Infrastructure Trust PLC (PGIT.L)'s net margin of 0.00%. RTW Biotech Opportunities' return on equity of 36.01% beat Premier Global Infrastructure Trust PLC (PGIT.L)'s return on equity.

Company Net Margins Return on Equity Return on Assets
RTW Biotech Opportunities158.61% 36.01% -0.47%
Premier Global Infrastructure Trust PLC (PGIT.L) N/A N/A N/A

RTW Biotech Opportunities has higher revenue and earnings than Premier Global Infrastructure Trust PLC (PGIT.L). Premier Global Infrastructure Trust PLC (PGIT.L) is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04
Premier Global Infrastructure Trust PLC (PGIT.L)-£2.54M0.00N/A-£40.70N/A

3.1% of RTW Biotech Opportunities shares are owned by institutional investors. 0.6% of RTW Biotech Opportunities shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

RTW Biotech Opportunities beats Premier Global Infrastructure Trust PLC (PGIT.L) on 7 of the 8 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to Dunedin Enterprise Investment Trust?

Dunedin Enterprise Investment Trust (LON:DNE) and RTW Biotech Opportunities (LON:RTW) are both small-cap financial services companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

RTW Biotech Opportunities has a net margin of 158.61% compared to Dunedin Enterprise Investment Trust's net margin of 74.24%. RTW Biotech Opportunities' return on equity of 36.01% beat Dunedin Enterprise Investment Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Dunedin Enterprise Investment Trust74.24% 3.62% 2.87%
RTW Biotech Opportunities 158.61%36.01%-0.47%

Dunedin Enterprise Investment Trust has a beta of 0.46, suggesting that its share price is 54% less volatile than the broader market. Comparatively, RTW Biotech Opportunities has a beta of 1.238194, suggesting that its share price is 24% more volatile than the broader market.

32.6% of Dunedin Enterprise Investment Trust shares are held by institutional investors. Comparatively, 3.1% of RTW Biotech Opportunities shares are held by institutional investors. 68.6% of Dunedin Enterprise Investment Trust shares are held by insiders. Comparatively, 0.6% of RTW Biotech Opportunities shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

RTW Biotech Opportunities has higher revenue and earnings than Dunedin Enterprise Investment Trust. Dunedin Enterprise Investment Trust is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dunedin Enterprise Investment Trust£1.99M0.00£1.56M£28.41N/A
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04

In the previous week, Dunedin Enterprise Investment Trust's average media sentiment score of 0.00 equaled RTW Biotech Opportunities'average media sentiment score.

Company Overall Sentiment
Dunedin Enterprise Investment Trust Neutral
RTW Biotech Opportunities Neutral

Summary

RTW Biotech Opportunities beats Dunedin Enterprise Investment Trust on 6 of the 10 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to Digital 9 Infrastructure?

RTW Biotech Opportunities (LON:RTW) and Digital 9 Infrastructure (LON:DGI9) are both small-cap financial services companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings, valuation and media sentiment.

In the previous week, RTW Biotech Opportunities' average media sentiment score of 0.00 equaled Digital 9 Infrastructure'saverage media sentiment score.

Company Overall Sentiment
RTW Biotech Opportunities Neutral
Digital 9 Infrastructure Neutral

RTW Biotech Opportunities has higher revenue and earnings than Digital 9 Infrastructure. Digital 9 Infrastructure is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04
Digital 9 Infrastructure-£211.22M-0.12-£456.44M-£25.10N/A

RTW Biotech Opportunities has a net margin of 158.61% compared to Digital 9 Infrastructure's net margin of -4,631.60%. RTW Biotech Opportunities' return on equity of 36.01% beat Digital 9 Infrastructure's return on equity.

Company Net Margins Return on Equity Return on Assets
RTW Biotech Opportunities158.61% 36.01% -0.47%
Digital 9 Infrastructure -4,631.60%-74.80%N/A

3.1% of RTW Biotech Opportunities shares are held by institutional investors. Comparatively, 23.4% of Digital 9 Infrastructure shares are held by institutional investors. 0.6% of RTW Biotech Opportunities shares are held by insiders. Comparatively, 0.8% of Digital 9 Infrastructure shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

RTW Biotech Opportunities beats Digital 9 Infrastructure on 7 of the 10 factors compared between the two stocks.

Get RTW Biotech Opportunities News Delivered to You Automatically

Sign up to receive the latest news and ratings for RTW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RTW vs. The Competition

Export
MetricRTW Biotech OpportunitiesAsset Management IndustryFinancial SectorLON Exchange
Market Cap£7.25M£2.45B£6.07B£2.78B
Dividend YieldN/A6.03%5.27%6.16%
P/E Ratio0.0425.8716.31365.72
Price / Sales0.032,081.971,100.8786,253.69
Price / Cash0.3260.1684.9827.85
Price / Book0.011.376.637.92
Net Income£14.09B£264.62M£1.13B£5.89B
7 Day Performance0.90%-0.51%-0.23%-0.93%
1 Month Performance2.75%-0.17%1.00%-0.76%
1 Year Performance94.78%9.71%19.70%69.29%

RTW Biotech Opportunities Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RTW
RTW Biotech Opportunities
N/AGBX 2.24
+0.9%		N/A+93.1%£7.25M£250.89M0.044,971
CIP
CIP Merchant Capital
N/AN/AN/AN/A£27.50M£8.87M3.65N/A
RSE
Riverstone Energy
N/AGBX 554
-1.9%		N/A-31.8%£26.71M£31.65MN/AN/A
PGIT
Premier Global Infrastructure Trust PLC (PGIT.L)
N/AN/AN/AN/A£26.23M-£2.54MN/AN/A
DNE
Dunedin Enterprise Investment Trust
N/AN/AN/AN/A£26.15M£1.99M16.72N/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:RTW) was last updated on 6/24/2026 by MarketBeat.com Staff.
From Our Partners
My feud with Zohran Mamdani
Nearly 40% of Americans now hold a positive view of socialism - and former hedge fund manager Whitney Tilson s...
Stansberry Research | Sponsoredtc pixel
Quick favor to ask you
Bill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...
Profits Run | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Top Banks Warn: A Strange Day is Coming to America
Goldman Sachs and Morgan Stanley are warning clients about a developing crisis that could suppress portfolio g...
TradeSmith | Sponsoredtc pixel
A drilling crew just broke a record nobody expected
A drilling crew in Beaver County, Utah hit 15,765 feet of solid granite in 16 days - a job the Department of E...
Behind the Markets | Sponsoredtc pixel
Read this before you touch SPCX
SPCX is live on Nasdaq - but a market expert who called AMD before it climbed as high as 7,100% says buying th...
Altimetry | Sponsoredtc pixel
Millionaire trader who went 13-for-13 on Trump in 2025 now turns his attention to Elon.
Hedge fund trader Larry Benedict went 13-for-13 in Q1 2025 - not a single losing trade - and finished the year...
Brownstone Research | Sponsoredtc pixel
Karp just filed Form 144
On May 12, 2026, Palantir CEO Alex Karp filed to sell 585,000 shares - roughly $95.93 million. Combined with f...
Porter & Company | Sponsoredtc pixel